Cadrenal Therapeutics Inc (CVKD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2022 | 03-2022 | |
| Operating Expenses | 482 | 171 |
| Operating Income | -482 | -171 |
| Interest Expense | 15 | 5 |
| Other Income | 5 | -2 |
| Pre-tax Income | -492 | -177 |
| Net Income Continuous | -492 | -177 |
| Net Income | $-492 | $-177 |
| EPS Basic Total Ops | -1.05 | -0.30 |
| EPS Basic Continuous Ops | -0.96 | -0.35 |
| EPS Diluted Total Ops | -1.05 | -0.30 |
| EPS Diluted Continuous Ops | -0.96 | -0.35 |
| EBITDA(a) | $-474 | $-168 |